- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT01210872
Quality-Of-Life Assessment in Patients With Head and Neck Cancer Treated With Radiation Therapy
Impact of Quality of Life Assessment in Routine Oncology Practice for Head and Neck's Cancer Patients, Treated by Radiotherapy: Impact on the Satisfaction With Care, the Health Related Quality of Life and on the Toxicity
RATIONALE: Gathering information over time about patients' quality-of-life and satisfaction with care may help doctors plan the best treatment and help patients live more comfortably.
PURPOSE: This randomized clinical trial is studying quality-of-life assessment in patients with head and neck cancer treated with radiation therapy.
Studieoversikt
Status
Forhold
Detaljert beskrivelse
OBJECTIVES:
Primary
- To evaluate the impact of quality-of-life assessment in routine oncology practice on satisfaction with care, health-related quality-of-life, and toxicity in patients with primary nonmetastatic head and neck cancer treated with radiotherapy.
Secondary
- To evaluate the feasibility of using quality-of-life tools in routine oncology practice.
- To evaluate the impact on the occurrence of toxicity.
- To determine the impact on overall survival.
- To study the concordance between the toxicity reported by the clinician and those reported by the patient quality-of-life questionnaires.
OUTLINE: Patients are stratified according to sex, tumor localization, and TNM stage. Patients are randomized to 1 of 2 arms.
- Arm I: Patients complete quality-of-life questionnaires (EORTC tools only, including EORTC QLQ-SAT32, EORTC QLQ-C30, and specific module QLQ-H&N35/Euroqol EQ-5D) before each consultation with the clinician for one year.
- Arm II: Patients undergo standard follow-up care comprising consultation with the clinician for one year.
After completion of study, patients are followed up every 3 months for 1 year and then at 2 years.
Studietype
Registrering (Forventet)
Kontakter og plasseringer
Studiesteder
-
-
-
Dijon, Frankrike, 21079
- Rekruttering
- Centre de Lutte Contre le Cancer Georges-Francois Leclerc
-
Ta kontakt med:
- Contact Person
- Telefonnummer: 33-3-8073-7784
- E-post: pmaingon@dijon.fnclcc.fr
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
DISEASE CHARACTERISTICS:
- Diagnosis of primary nonmetastatic head and neck cancer
- No other primary cancer localizations
- No second tumor localization at the time of diagnosis
- Must be planning to be treated initially with radiotherapy
PATIENT CHARACTERISTICS:
- No cognitive impairment or psychiatric history
- No history of other cancer
PRIOR CONCURRENT THERAPY:
- No prior chemotherapy or radiotherapy
Studieplan
Hvordan er studiet utformet?
Hva måler studien?
Primære resultatmål
Resultatmål |
---|
Satisfaction of care (EORTC QLQ-SAT32)
|
Quality of life (EORTC QLQ-C30 and specific module QLQ-H&N35/Euroqol EQ-5D)
|
Sekundære resultatmål
Resultatmål |
---|
Total overlevelse
|
Toxicity (occurrence and length) according to NCI-CTC version 3.0
|
Samarbeidspartnere og etterforskere
Sponsor
Etterforskere
- Studiestol: Philippe Maingon, MD, Centre Georges Francois Leclerc
- Franck Bonnetain, PhD, Centre Georges Francois Leclerc
Studierekorddatoer
Studer hoveddatoer
Studiestart
Primær fullføring (Forventet)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Anslag)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Anslag)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
- stadium III plateepitelkarsinom i leppe og munnhule
- stadium III plateepitelkarsinom i orofarynx
- stadium III lymfepitelom i orofarynx
- stadium III plateepitelkarsinom i nasopharynx
- stadium III lymfepitelom i nasofarynx
- stadium III plateepitelkarsinom i hypopharynx
- stadium III plateepitelkarsinom i strupehodet
- stadium III verrucous karsinom i strupehodet
- stadium I plateepitelkarsinom i leppe og munnhule
- stadium II plateepitelkarsinom i leppe og munnhule
- stadium I plateepitelkarsinom i hypopharynx
- stadium I plateepitelkarsinom i strupehodet
- stadium I plateepitelkarsinom i nasopharynx
- stadium I plateepitelkarsinom i orofarynx
- stadium II plateepitelkarsinom i hypopharynx
- stadium II plateepitelkarsinom i strupehodet
- stadium II plateepitelkarsinom i nasopharynx
- stadium II plateepitelkarsinom i orofarynx
- tungekreft
- stadium I verrucous karsinom i strupehodet
- stadium II verrucous karsinom i strupehodet
- stadium I lymfepitheliom i nasopharynx
- stadium II lymfepitheliom i nasopharynx
- stadium I lymfepitheliom i orofarynx
- stadium II lymfepitelom i orofarynx
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- CGFL-QDV
- CDR0000683850 (Registeridentifikator: PDQ (Physician Data Query))
- CGFL-AFSSAPS-2008-A01468-47
- EU-21061
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på spørreskjemaadministrasjon
-
Cairn DiagnosticsFullført
-
PATHMinistry of Health, Zambia; AKROS Global HealthFullført
-
Analgesic SolutionsGrünenthal GmbHFullførtSmertefull diabetisk nevropati (PDN)Forente stater
-
Gerd MikusFullført
-
Wayne State UniversityUkjentOpioidavhengighet | Opioidbruk | BenbruddForente stater
-
University of California, San FranciscoNational Institute of Allergy and Infectious Diseases (NIAID); Stanford... og andre samarbeidspartnereHar ikke rekruttert ennå
-
Nanfang Hospital of Southern Medical UniversityHar ikke rekruttert ennåKjemoterapi-indusert perifer nevropati | AcetylkarnitinKina
-
University of Alabama at BirminghamTilbaketrukketRespirasjonsdepresjon
-
Boehringer IngelheimFullført
-
Universitas Negeri SemarangMinistry of Research, Technology and Higher Education, Republic of IndonesiaUkjentOksidativt stress | Anstrengelse; OverskuddIndonesia